Accessibility options
Translate the page
AI must move beyond pilots to deliver an inclusive and productive NHS, concludes inaugural ABHI and Barts Health Forum Roundtable
Leaders from across the NHS, government, industry and academia have called for a fundamental shift in how artificial intelligence is adopted across the health service, arguing that the NHS must move beyond isolated pilots and create clearer, faster routes to deployment if it is to realise the full benefits of AI. The conclusions come from the inaugural ABHI and Barts...
Continue Reading
Rakesh Uppal comments on London Life Sciences Strategy
Writing for Healthcare Today, Rakesh Uppal, chief executive of Barts Life Sciences, says that an ambitious life sciences strategy for London demands equally ambitious partnerships. I welcome the publication of London’s Life Sciences Strategy, ambitious, but grounded in where London has fallen short. The strategy rightly identifies the challenge: creating the conditions for the NHS, academia and industry to work together more...
Continue Reading
Barts Life Sciences supporting real-world evaluation of new AI heart failure screening tool
Barts Life Sciences is playing a central role in bringing a pioneering new AI screening tool closer to routine NHS use. Developed by clinicians and researchers at Barts Health and Queen Mary University of London, the Intelligent Heart Evaluation Framework (iHeF) uses a simple electrocardiogram (ECG) to detect subtle changes in heart function that currently require specialist hospital imaging. Backed by £1.3m from the National...
Continue Reading
King Charles visits Pharos AI project
Barts Life Sciences welcome the visit of His Majesty The King to the Innovation Hub at Guy’s Cancer Centre, where we and partners are advancing cancer research through collaboration. At the Hub, scientists are working across disciplines, from data science to genomics, to integrate cutting-edge research directly into patient pathways, enabling more precise and tailored treatment. Central to this is...
Continue Reading
Barts Life Sciences Cluster highlighted at Prime Minister’s Questions
At today’s Prime Minister’s Questions, Rushanara Ali MP highlighted the Barts Life Sciences Cluster as one of the UK’s emerging leading life sciences clusters, with £800m in private investment secured to date. She emphasised the opportunity to turn health inequalities in east London into a powerful driver of UK life sciences growth, transforming the future of healthcare in London, across...
Continue Reading